{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:23:53Z","timestamp":1770823433256,"version":"3.50.1"},"reference-count":9,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T00:00:00Z","timestamp":1345161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasmablastic lymphoma shares many morphologic features with plasmablastic plasma cell myeloma. The activation of MYC oncogene in these lymphomas may be an important pathogenetic element associated with Epstein\u2013Barr virus infection. We describe herein an elderly man with a plasmablastic lymphoid neoplasm displaying unique morphologic, cytogenetic and clinical features. This case might offer additional insights to the complex but fascinating topic of hybrid haemato\u2010lymphoid neoplasms such as plasmablastic lymphoma\u2010myeloma. In addition, the patient responded to the treatment with bortezomib. Newer antimyeloma agents such as bortezomib have shown promise in the treatment of these neoplasms and should further be explored for their therapy. Copyright \u00a9 2012 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hon.2024","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T10:49:21Z","timestamp":1345200561000},"page":"164-166","source":"Crossref","is-referenced-by-count":18,"title":["Plasmablastic haemato\u2010lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib"],"prefix":"10.1002","volume":"31","author":[{"given":"Constantin A.","family":"Dasanu","sequence":"first","affiliation":[{"name":"Department of Hematology\u2013Oncology Saint Francis Hospital and Medical Center  Hartford CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Anatomic and Clinical Pathology Saint Francis Hospital and Medical Center  Hartford CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ion","family":"Codreanu","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging University of Arizona Medical Center  Tucson AZ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premkumar","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Connecticut Health Science Center  Farmington CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murtuza","family":"Rampurwala","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Connecticut Health Science Center  Farmington CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,17]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.523"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800355"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000126781.87158.e3"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-180315"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.0038"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.06.036"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181f3e29f"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.074"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"e19562","DOI":"10.1200\/jco.2009.27.15_suppl.e19562","article-title":"Response of AIDS\u2010related plasmablastic lymphoma (PBL) to bortezomib","volume":"27","author":"Bose P","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2024","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T05:08:33Z","timestamp":1700629713000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,17]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1002\/hon.2024"],"URL":"https:\/\/doi.org\/10.1002\/hon.2024","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,17]]}}}